KATHLEEN BOETTCHER: Open Payments
NPI 1669472551 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 32 payments from 13 companies in 2025. Trend: 2023 $620 · 2024 $994 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $181 |
| Novo Nordisk Inc | 2 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| CVRx, Inc. | 1 | $62 |
| SCPHARMACEUTICALS INC. | 3 | $56 |
| PFIZER INC. | 2 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $27 |
Products named: Wegovy, LEQVIO, KRYSTEXXA, REPATHA, Kerendia, CAMZYOS, Barostim Neo System, FUROSCIX.
Industry payments across GA — which companies pay providers there.
